iNOs-IN-3 (Compound 2d) 是一种具有口服活性的一氧化氮合成酶 (iNOS) 抑制剂 (IC50=3.342 μM)。iNOs-IN-3 具有抗炎活性,可用于 LPS 诱导的急性肺损伤 (ALI) 研究。
生物活性 | iNOs-IN-3 (Compound 2d) is an orally active nitric oxide synthase (iNOS) inhibitor (IC50=3.342 μM). iNOs-IN-3 shows anti-inflammatory activity and can be used in LPS-induced acute lung injury (ALI) research[1]. |
IC50& Target | |
体外研究 (In Vitro) | iNOs-IN-3 (25 μM; 24 h) inhibits LPS-induced RAW 264.7 cells[1]. iNOs-IN-3 (12.5 μM; 24 h) can decrease the expression of iNOS[1].
Cell Viability Assay[1] Cell Line: | RAW 264.7 microphages | Concentration: | 25 μM | Incubation Time: | 24 hours | Result: | Showed higher inhibitory activity (IC50=14.72 μM) in LPS-induced RAW 264.7 cells. |
Cell Viability Assay[1] Cell Line: | RAW 264.7 microphages | Concentration: | 12.5 μM | Incubation Time: | 24 hours | Result: | Inhibited the LPS-induced mRNA expression of iNOS obviously. |
Cell Viability Assay[1] Cell Line: | RAW 264.7 microphages | Concentration: | 12.5 μM | Incubation Time: | 24 hours | Result: | Inhibited the expression of TNF-α, IL-6, and IL-1β at 12.5 μM. |
|
体内研究 (In Vivo) | iNOs-IN-3 (oral administration; 12.5 mg/kg; once) treatment shows anti-inflammatory activity against xylene-induced ear edema in mice[1]. iNOs-IN-3 (oral administration; 3.125 mg/kg, 6.25 mg/kg, 12.5 mg/kg; once) protects against LPS-induced acute lung injury[1].
Animal Model: | Xylene-induced mice[1] | Dosage: | 12.5 mg/kg | Administration: | Oral administration; 12.5 mg/kg; once | Result: | Showed better activity than the positive control. |
Animal Model: | LPS-induced acute lung injury (ALI) mice[1] | Dosage: | 3.125 mg/kg, 6.25 mg/kg, 12.5 mg/kg | Administration: | Oral administration; 3.125 mg/kg, 6.25 mg/kg, 12.5 mg/kg; once | Result: | Attenuated the pathological lesions dose-dependently, such as decreased inflammatory infiltration and pulmonary congestion. Inhibited LPS-induced lung edema dose-dependently. |
|
分子量 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |